| identifier: | 1811764 |
| description: |
epitope description:alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc
antigen name:Variant surface glycoprotein (VSG, atypical), putative (UniProt:Q380X5)
host organism:Camelus dromedarius
antibody name:NbAn33-Tr-Apo-L-I
|
| aggregation: |
instance of dataset
|
| availability: |
available
|
| primaryPublications: |
16604085 |
| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1003946 |
| landingPage: |
http://www.iedb.org/assay/1811764 |
| type: |
Literature
|
| publicationVenue: |
Nat Med
|
| dates: |
2006
|
| study type: | b cell assays |
| subject species: | Trypanosoma brucei brucei |
| fullName: |
Toya Nath Baral
Stefan Magez
Benoî
t Stijlemans
Katja Conrath
Benoit Vanhollebeke
Etienne Pays
Serge Muyldermans
Patrick De Baetselier
|
| method: |
immuno staining
|
| name: |
Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.
|
| description: |
This branched high-mannose oligosaccaride (Man9-GlcNAc2) is expressed at the Variable surface Glycoproteins (VSG) of T. brucei brucei and T. b. rhodesiense.
A construct of the epitope-specific camelid VHH fragment NbAn33 and the T. brucei-lytic enzyme apo-L-I is able to stain blood smears and cell suspensions of a T. b. brucei AnTat 1.1 infected mouse.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |